Astria Therapeutics, Inc. (ATXS) Reports In-Line Q3 EPS

Astria Therapeutics, Inc. (NASDAQ: ATXS) reported Q3 EPS of ($0.42), in-line with the analyst estimate of ($0.42).

For earnings history and earnings-related data on Astria Therapeutics, Inc. (ATXS) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Deere shares climb as fiscal Q3 earnings and revenue top estimates
• Samsung Plans As Much As $79 Billion In Shareholder Returns - Bloomberg